Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer. JAMA Oncol 2018 Sep 01;4(9):1287-1288
Date
06/01/2018Pubmed ID
29852036Pubmed Central ID
PMC6117101DOI
10.1001/jamaoncol.2018.1258Scopus ID
2-s2.0-85053299313 (requires institutional sign-in at Scopus site) 162 CitationsAbstract
This study evaluates 5-year data from the NRG Oncology RTOG 0236 trial on the effects of sterotactic body radiation therapy in patients with inoperable stage I non–small cell lung cancer.
Author List
Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy HAuthor
David Johnstone MD Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Carcinoma, Non-Small-Cell LungDisease-Free Survival
Humans
Lung Neoplasms
Neoplasm Recurrence, Local
Neoplasm Staging
Radiosurgery
Time Factors
Treatment Outcome
